Innate Pharma ADR reports 1H results

Innate Pharma ADR (): 1H GAAP EPS of -€0.28.

Revenue of €23.67M (+11.7% Y/Y)

Now read:

for full text news in your inbox

Leave a Reply

Your email address will not be published. Required fields are marked *

*